First Hawaiian Bank United Therapeutics Corp Transaction History

First Hawaiian Bank

  • $2.84 Billion
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 15, 2019
SELL
$76.06 - $120.81 $91,272 - $144,972
-1,200 Closed
0 $0
Q1 2019

Apr 02, 2019
BUY
$107.15 - $126.84 $97,506 - $115,424
910 Added 313.79%
1,200 $141,000
Q3 2018

Oct 16, 2018
BUY
$113.81 - $129.46 $33,004 - $37,543
290 New
290 $37,000

Others Institutions Holding UTHR

# of Institutions
731
Shares Held
40.8M
Call Options Held
123K
Put Options Held
104K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $13B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email